Anti-CD3 & CLDN-18.2 Reference Antibody (gresonitamab)
Produktgrößen
100 ug
£ POA
CHB458-100UG
Über dieses Produkt
- SKU:
- CHB458
- Anwendung:
- Cell-based/Functional Assay, Detection/Quantitation, ELISA, FACS, Flow Cytometry
- translate.label.attr.clone:
- gresonitamab
- Klonalität:
- Recombinant Monoclonal
- Weitere Details:
- Anti-CD3 & CLDN-18.2 Reference Antibody (gresonitamab) (CHB458) is expressed from CHO, with a configuration of HLE-BiTE. The heavy chain type is huIgG1-scFv. It has a predicted MW of 106.15 kDa.
- Immunogen:
- CD3 & CLDN-18.2
- Isotyp:
- IgG
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- Sanyou Biopharmaceuticals
- Typ:
- Antibody: Biosimilar Antibody
- Datenblatt des Herstellers:CHB458